COMP <GO>

DRTS vs TNDM // FORWARD P/E MULTIPLE

Alpha Tau Medical Ltd. (NASDAQ) VS. Tandem Diabetes Care Inc. (NASDAQ) • 15-METRIC TALLY: DRTS 0 — TNDM 4

■ METRIC PARITY

LAST: $13.23 (-0.90%) • MKT CAP: $1.22B

forward-pe

—

LAST: $19.79 (+0.56%) • MKT CAP: $1.38B

forward-pe

—

15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (DRTS VS. TNDM) EMERALD CELL = QUANTITATIVE EDGE

INSTITUTIONAL METRIC	DRTS	TNDM	SPREAD (A - B)	ADVANTAGE	DEDICATED URL
Gross Profit Margin	—	53.80%	—	TIE	/gross-margins <GO>
Return on Invested Capital (ROIC)	-35.00%	-35.00%	0.00	TIE	/roic <GO>
EV/EBITDA & P/E Valuation	—	—	—	TIE	/valuation <GO>
Free Cash Flow Yield	-2.68%	-2.15%	-0.53	TNDM	/fcf-yield <GO>
Operating Margin	—	-18.50%	—	TIE	/operating-margins <GO>
Net Profit Margin	—	-20.20%	—	TIE	/net-margins <GO>
Revenue Growth (YoY)	—	7.90%	—	TIE	/revenue-growth <GO>
Dividend Yield & FCF Payout Safety	0.00%	0.00%	0.00	TIE	/dividend-safety <GO>
Altman Z-Score & Debt/Equity	—	0.20	—	TIE	/balance-sheet <GO>
Piotroski F-Score Quality	2/9	4/9	-2.00	TNDM	/piotroski-score <GO>
Options Implied Move & Put/Call Skew	—	—	—	TIE	/options-implied-move <GO>
RSI-14 & 200D SMA Momentum	43.3	62.4	-19.09	TNDM	/rsi-technicals <GO>
10Y Yield & FRED Macro Beta	—	—	—	TIE	/macro-sensitivity <GO>
Forward P/E Multiple ACTIVE	—	—	—	TIE	/forward-pe <GO>
Enterprise Scale & Market Cap	$1.22B	$1.38B	-$153.5M	TNDM	/market-cap <GO>

5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY

FISCAL YEAR	DRTS REV	TNDM REV	DRTS GROSS %	TNDM GROSS %	DRTS FCF	TNDM FCF
FY 2025	$0	$1.01B	—	53.8%	-$32.8M	-$29.7M
FY 2024	$0	$940.2M	—	52.1%	-$22.0M	$5.0M
FY 2023	$0	$747.7M	—	—	-$18.0M	-$31.8M

FRED MACRO REGIME CORRELATION COMPARISON PEARSON r

DRTS // BETA —

TNDM // BETA —